Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker

Figure 4

Phosphorylation analysis of CDK1 protein in different tumors. (a) Based on the CPTAC dataset, we analyzed the expression level of CDK1 phosphoprotein (NP_001307847.1, T14, Y15, and T161 sites) between normal tissue and primary tissue of selected tumors via the UALCAN. The phosphoprotein sites with positive results are displayed in the schematic diagram of the CDK1 protein. (b) Box plots of CDK1 protein phosphorylation in different tumors.

(a)

(b)